119 related articles for article (PubMed ID: 12143154)
41. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM
Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742
[TBL] [Abstract][Full Text] [Related]
42. Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine.
Kobashigawa JA
Transplant Proc; 1998 Jun; 30(4):1095-7. PubMed ID: 9636445
[No Abstract] [Full Text] [Related]
43. Drug-related dyslipidemia after renal transplantation.
Mathis AS; Davé N; Knipp GT; Friedman GS
Am J Health Syst Pharm; 2004 Mar; 61(6):565-85; quiz 586-7. PubMed ID: 15061429
[TBL] [Abstract][Full Text] [Related]
44. Influence of tacrolimus and prednisone on serum lipids after liver transplantation.
Scolapio JS; Bowen J; Lukens FJ; Ukleja A; Atkinson E
JPEN J Parenter Enteral Nutr; 2001; 25(3):148-51. PubMed ID: 11334064
[TBL] [Abstract][Full Text] [Related]
45. New-onset diabetes mellitus after pediatric liver transplantation.
Regelmann MO; Goldis M; Arnon R
Pediatr Transplant; 2015 Aug; 19(5):452-9. PubMed ID: 26032592
[TBL] [Abstract][Full Text] [Related]
46. [New developments in immunosuppressive therapy].
Hopt UT
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():620-3. PubMed ID: 11824327
[TBL] [Abstract][Full Text] [Related]
47. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
Chakkera HA; Kudva Y; Kaplan B
Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122
[TBL] [Abstract][Full Text] [Related]
48. Overview of side effects of immunosuppressive therapy.
Paul LC
Transplant Proc; 2001 May; 33(3):2089-91. PubMed ID: 11377462
[No Abstract] [Full Text] [Related]
49. Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation.
Cuoco L; Tursi A; Cammarota G; Papa A; Fedeli G; Gasbarrini G
Am J Gastroenterol; 1997 Nov; 92(11):2134-5. PubMed ID: 9362220
[No Abstract] [Full Text] [Related]
50. Sirolimus-induced severe hypertriglyceridemia in a lung transplant recipient.
Fernandez-Bussy S; Akindipe O; Baz M; Gosain P; Rosenberg A; Zumberg M
Transplantation; 2010 Feb; 89(4):481-2. PubMed ID: 20177353
[No Abstract] [Full Text] [Related]
51. Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.
Baran DA; Ashkar J; Galin ID; Sandler D; Segura L; Courtney MC; Correa R; Chan M; Lansman SL; Spielvogel D; Cheng J; Gass AL
Transplant Proc; 2002 Aug; 34(5):1711-2. PubMed ID: 12176547
[No Abstract] [Full Text] [Related]
52. Impact of immunosuppressive regimes on posttransplant diabetes mellitus.
Weir M
Transplant Proc; 2001 Aug; 33(5A Suppl):23S-26S. PubMed ID: 11498201
[No Abstract] [Full Text] [Related]
53. Rescue therapy: a role for sirolimus in lung and heart transplant recipients.
Snell GI; Levvey BJ; Chin W; Kotsimbos AT; Whitford H; Williams TJ; Richardson M
Transplant Proc; 2001; 33(1-2):1084-5. PubMed ID: 11267201
[No Abstract] [Full Text] [Related]
54. Renal complications after heart transplantation.
Bennett WM
Transplant Proc; 1999; 31(1-2):88. PubMed ID: 10083019
[No Abstract] [Full Text] [Related]
55. Renal failure after lung transplantation.
Fisher NC
Lancet; 1998 Jul; 352(9121):69-70. PubMed ID: 9800782
[No Abstract] [Full Text] [Related]
56. [Rhabdomyolysis in a patient treated with lovastatin and cyclosporine].
Hermida Lazcano I; Revillo Pinilla P; Nerin Sánchez C; Lechuga Durán I; Fernández López J
An Med Interna; 1997 Sep; 14(9):488. PubMed ID: 9453765
[No Abstract] [Full Text] [Related]
57. Lipids in liver transplant recipients.
Hüsing A; Kabar I; Schmidt HH
World J Gastroenterol; 2016 Mar; 22(12):3315-24. PubMed ID: 27022213
[TBL] [Abstract][Full Text] [Related]
58. [Side effects and toxicity of immunosuppressive agents].
Salvadori M; Bertoni E
G Ital Nefrol; 2003; 20(5):490-502. PubMed ID: 14634965
[TBL] [Abstract][Full Text] [Related]
59. Hyperlipidemia and glucose intolerance in the post-renal transplant patient.
Markell MS; Armenti V; Danovitch G; Sumrani N
J Am Soc Nephrol; 1994 Feb; 4(8 Suppl):S37-47. PubMed ID: 8193294
[TBL] [Abstract][Full Text] [Related]
60. FK506-induced autoimmune diabetes.
Kawai T; Shimada A; Kasuga A
Ann Intern Med; 2000 Mar; 132(6):511. PubMed ID: 10733461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
